177 related articles for article (PubMed ID: 7510815)
1. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
Küpfer A; Aeschlimann C; Wermuth B; Cerny T
Lancet; 1994 Mar; 343(8900):763-4. PubMed ID: 7510815
[TBL] [Abstract][Full Text] [Related]
2. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
Küpfer A; Aeschlimann C; Cerny T
Eur J Clin Pharmacol; 1996; 50(4):249-52. PubMed ID: 8803513
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide induced encephalopathy in a child with osteosarcoma.
Sarbay H; Demir ÜF; Yılmaz G; Atay AA; Malbora B
J Oncol Pharm Pract; 2021 Jul; 27(5):1302-1306. PubMed ID: 33023384
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
Aeschlimann C; Cerny T; Küpfer A
Drug Metab Dispos; 1996 Dec; 24(12):1336-9. PubMed ID: 8971139
[TBL] [Abstract][Full Text] [Related]
5. Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Gharaibeh EZ; Telfah M; Powers BC; Salacz ME
J Oncol Pharm Pract; 2019 Oct; 25(7):1784-1786. PubMed ID: 30348070
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy.
Aeschlimann C; Küpfer A; Schefer H; Cerny T
Drug Metab Dispos; 1998 Sep; 26(9):883-90. PubMed ID: 9733667
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.
Richards A; Marshall H; McQuary A
J Oncol Pharm Pract; 2011 Dec; 17(4):372-80. PubMed ID: 20861178
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue for management of Ifosfamide-induced encephalopathy.
Patel PN
Ann Pharmacother; 2006 Feb; 40(2):299-303. PubMed ID: 16391008
[TBL] [Abstract][Full Text] [Related]
9. Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
Duflot T; Marie-Cardine A; Verstuyft C; Filhon B; Pereira T; Massy-Guillemant N; Joannidès R; Bellien J; Lamoureux F
Fundam Clin Pharmacol; 2018 Jun; 32(3):337-342. PubMed ID: 29319893
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide-induced encephalopathy and movement disorder.
Ames B; Lewis LD; Chaffee S; Kim J; Morse R
Pediatr Blood Cancer; 2010 Apr; 54(4):624-6. PubMed ID: 19953647
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue reversal of ifosfamide-related encephalopathy.
Raj AB; Bertolone SJ; Jaffe N
J Pediatr Hematol Oncol; 2004 Feb; 26(2):116. PubMed ID: 14767201
[No Abstract] [Full Text] [Related]
12. Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Brunello A; Basso U; Rossi E; Stefani M; Ghiotto C; Marino D; Crivellari G; Monfardini S
Drugs Aging; 2007; 24(11):967-73. PubMed ID: 17953463
[TBL] [Abstract][Full Text] [Related]
13. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
14. Hearing loss during osteosarcoma chemotherapy: when acute ifosfamide toxicity revealed unnoticed methotrexate encephalopathy.
Robert G; Chappé C; Taque S; Bruneau B; Gandemer V
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e100-2. PubMed ID: 24309600
[TBL] [Abstract][Full Text] [Related]
15. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide-induced encephalopathy with or without using methylene blue.
Park IS; Lee HJ; Lee YS; Hwang JS; Lee MS
Int J Gynecol Cancer; 2005; 15(5):807-10. PubMed ID: 16174228
[TBL] [Abstract][Full Text] [Related]
17. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
18. Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.
McDonnell AM; Rybak I; Wadleigh M; Fisher DC
J Oncol Pharm Pract; 2012 Dec; 18(4):436-9. PubMed ID: 22235061
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of ifosfamide induced encephalopathy with methylene-blue].
Ferrero JM; Eftekari P; Largillier R; Dreyfus G; Namer M
Bull Cancer; 1995 Jul; 82(7):598-9. PubMed ID: 7549123
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
Cherry MA; Bhardwaj H; Hopps S; Srour S; Pant S
J Oncol Pharm Pract; 2013 Sep; 19(3):261-4. PubMed ID: 23135805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
